DIAGNOSIS OF SEPSIS BY THE SELECTIVE DETERMINATION OF THE CONCENTRATION OF CU/ZN SUPEROXIDE DISMUTASE (CU/ZN SOD) IN PATIENT SAMPLES

摘要

The invention relates to a method for the early determination of the risk of mortality of patients in intensive care units or emergency care units during which the concentration of Cu/Zn superoxide dismutase (Cu/Zn SOD or SOD-1) in a serum sample or plasma sample of a patient of this type is selectively determined, and quantitatively or semiquantitatively measured concentrations, which exceed a predetermined threshold value, e.g. greater than approximately 310 ng/ml, are correlated with a high risk of mortality.